Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)

Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses

(2018) Astrid Alflen et al.   Scientific Reports

Cryptococcal infections in two patients receiving ibrutinib therapy for chronic lymphocytic leukemia

(2018) Matthew Stankowicz et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

(2017) Srdan Verstovsek et al.   Journal of Hematology & Oncology

Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity

(2017) Alexander N. R. Weber et al.   Frontiers in Immunology

Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30+ Lymphoma

(2017) Jean-Jacques Tudesq et al.   Open Forum Infectious Diseases

In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection

(2016) Perry Tsai et al.   Retrovirology

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis

(2016) Krista Dubin et al.   Nature Communications

Ibrutinib-induced pneumonitis in patients with chronic lymphocytic leukemia

(2015) A. R. Mato et al.   BLOOD

Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy

(2015) Joel D. Leverson et al.   Science Translational Medicine

mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis

(2015) Xishao Xie et al.   BMC Nephrology

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

(2014) G Zugmaier et al.   Blood Cancer Journal

Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes

(2014) Richard Brad Jones et al.   PLoS Pathogens

mTOR inhibitor-related pulmonary toxicity; incidence even higher

(2013) Anna E. C. A. B. Willemsen et al.   ACTA ONCOLOGICA

PI3K signalling: the path to discovery and understanding

(2012) Bart Vanhaesebroeck et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The emerging mechanisms of isoform-specific PI3K signalling

(2010) Bart Vanhaesebroeck et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY